Stem cell therapy: How American CryoStem is leading the way in preparing individuals for personalized regenerative medicine

American CryoStem (OTCMKTS: CRYO) is focusing on adipose tissue (fat) stem cell storage, innovating state of the art technology to collect, process and extract for regenerative and personalized medicine
(PR NewsChannel) / July 14, 2016 / EATONTOWN, NJ. 

American CryostemWhile as Americans, we collectively spend billions of dollars trying to get rid of excess fat, a publicly traded company (OTCMKTS: CRYO) based in Eatontown, NJ is making a business out of collecting, transporting, processing and cryo-storing adipose tissue (fat) and the Mesenchymal stem cells contained in the tissue to create regenerative medicine applications and topical anti-aging products.

Founded in 2008, American CryoStem is a developer, marketer and global licensor of patented adipose tissue (fat) stem cell technologies.

“We maintain a strategic portfolio of intellectual property and patent applications which supports and promotes a growing pipeline of biologic products and processes, clinical services and international licensing opportunities,” says John S. Arnone, Chairman of American CryoStem.

Harvesting fat, and the adipose derived adult stem cells (ADSC’s) contained in the tissue is an effective way to regulate the body’s immune system today or in the future. According to Researchers at the Leiden University Medical Center’s Department of Immunohematology and Blood Transfusion in Leiden, The Netherlands, it is actually more effective than stem cells collected from bone marrow.

“Adipose tissue is an interesting alternative since it contains approximately a 500-fold higher frequency of stem cells than bone marrow. Tissue collection is simple,” says Helene Roelofs, Ph.D., who conducted the study which was published in the May 2013 issue of STEM CELLS TRANSLATIONAL MEDICINE.

Other studies have shown fat stem cells to be effective at treating Crohn’s disease, pulmonary disease, Parkinson’s and various auto-immune diseases. It also has been shown to treat Alzheimer’s, Rheumatoid arthritis, multiple sclerosis, ALS, spinal cord injuries, coronary artery disease and a whole host of orthopedic applications.

Storing Fat Stem Cells

The Company says a growing number of healthy people nationwide are visiting their physician to extract as little as two ounces of their own fat tissue and cryo-preserving the pure tissue or the stem cells contained for future use in the event they are diagnosed with a disease or have an orthopedic issue, so they have a alternative treatment available. The tissue stem cells are also being used to create personalized skin care products so patients can topically regenerate their skin, too.

The practice of storing your own fat for cosmetic transfer in fat grafting procedures or storing the stem cells contained in the tissue has become popular in the US and around the world. American CryoStem says it has expanded its state-of-the-art FDA-registered, clinical laboratory in Princeton, New Jersey to meet this demand, and has opened licensed laboratories in Hong Kong, China, and Tokyo, Japan to keep up with growth from Asia markets.

“If you get one of these dreaded diseases, or a serious injury, studies have shown that it is possible to take those healthy stem cells and inject them into patients to repair the damaged tissue” says Rand McClain, DO, Medical and Scientific Advisory Board member. “It really is amazing. The process of extracting stem cells from fat and reintroducing them into the body allows the body the ability, in essence, to heal itself naturally.”

Regenerative Medicine

According to FDA guidance, while it’s OK to collect and transport adipose tissue (fat) and cryopreserve it for further use as a natural filler, it is not yet approved in the US., to manipulate the tissue and reintroduce your own healthy adipose derived stem cells into the body for stem cell therapy, even when it’s your own biological material.  For many years the medical industry has been working with bone marrow stem cells, Umbilical cord blood stem cells, and peripheral blood cells.  Adipose tissue (fat) cells are the new player on the block and are currently working their way through the FDA regulatory process.

The FDA guidance policy(s) is currently under review due to the outcry from physicians and patients looking to use their own biological material to heal and repair themselves. This September the FDA is expected to begin hearings relating to the regulation of Human Tissue Cells. As the FDA reviews its guidance related to Adipose derived stem cells, American CryoStem expects to see the number of people storing their stem cells for personalized regenerative medicine grow steadily. In the interim, American Cryostem says it has developed working relationships with medical facilities in the Cayman Islands, Costa Rica and other countries for Americans who want to undergo stem cell therapy and don’t want to wait.

“Storing your stem cells is an insurance policy, (bio-insurance), for your health,” says Arnone. “Who wouldn’t want to have a back-up plan that takes 30-45 minutes to put in place, an alternative plan that locks in your current biological cellular age to protect him or herself? As the body ages so do your stem cells.  This is very real and we’re thrilled to say we’re at the forefront of it.”

For more information about American CryoStem, please visit

Direct link:

SOURCE:  American CryoStem

This press release is distributed by PR NewsChannel. Your News. Everywhere.